E-Selectin

E-Selectin 詳細

英語名Selectin E市販薬剤の数0
治験薬の数4ターゲットの別称LECAM2,ELAM1,Endothelial leukocyte adhesion molecule 1,ELAM-1,SELE,Selectin E,CD62 Antigen-Like Family Member E,Leukocyte Endothelial Cell Adhesion Molecule 2,Leukocyte-Endothelial Cell Adhesion Molecule 2,CD62E Antigen,CD62E,ESEL,ELAM,Endothelial Adhesion Molecule 1,E-Selectin,E-selection
研究&開発段階Phase 3 Clinical
英語名Selectin E
ターゲットの別称LECAM2,ELAM1,Endothelial leukocyte adhesion molecule 1,ELAM-1,SELE,Selectin E,CD62 Antigen-Like Family Member E,Leukocyte Endothelial Cell Adhesion Molecule 2,Leukocyte-Endothelial Cell Adhesion Molecule 2,CD62E Antigen,CD62E,ESEL,ELAM,Endothelial Adhesion Molecule 1,E-Selectin,E-selection
市販薬剤の数0
治験薬の数4
研究&開発段階Phase 3 Clinical

E-Selectin 製品リスト

  • 属性

    Protein (3)

  • 製品ライブラリ

    オンライン (3)

  • Human (2)Mouse (1)

  • タグ

    His Tag (2)Fc Tag (1)

  • マーカー

    Unconjugated (3)

製品番号発現システム製品説明タンパク質の構造純度特性
CDE-H5222
Human
HEK293
Human E-Selectin / CD62E Protein, His Tag
CDE-H5250
Human
HEK293
Human E-Selectin / CD62E Protein, Fc Tag
CDE-M52H3
Mouse
HEK293
Mouse E-Selectin Protein, His Tag, low endotoxin (MALS verified)
総数量3
  • 1

E-Selectinバックグランド

E-Selectin is also known as CD62 antigen-like family member E (CD62E), endothelial-leukocyte adhesion molecule 1 (ELAM-1), or leukocyte-endothelial cell adhesion molecule 2 (LECAM2), a member of the Selectin family, is a 107-115 kDa cell surface glycoprotein. It is transiently expressed on vascular endothelial cells in response to IL-1β and TNFα. E selectin has a cassette structure: an N-terminal, C-type lectin domain, an EGF (epidermal-growth-factor)-like domain, 6 Sushi domain (SCR repeat) units, a transmembrane domain (TM) and an intracellular cytoplasmic tail (cyto). During inflammation, E-selectin plays an important part in recruiting leukocytes to the site of injury. The local release of cytokines IL-1 and TNF-α by damaged cells induces the over-expression of E-selectin on endothelial cells of nearby blood vessels. E-selectin mediates the adhesion of tumor cells to endothelial cells, by binding to E-selectin ligands expressed by neutrophils, monocytes, eosinophils, memory-effector T-like lymphocytes, natural killer cells or cancer cells. Furthermore, a number of studies have reported that levels of E-Selectin may be elevated in subjects with a variety of pathological conditions.

E-Selectin分子の別称

SELE,RP1-117P20.2,CD62E,ELAM1,ESEL,LECAM2,E-Selectin

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
UproleselanGMI-1271; APL-106Phase 3 ClinicalCrescent Biopharma IncCoronavirus Disease 2019 (COVID-19); Leukemia; Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasms; Venous Thrombosis
詳細
E-selectin targeting humanized antibody (LifeArc)Phase 1 ClinicalLifearcRespiratory Distress Syndrome, Adult; Sepsis
詳細
GMI-1687GMI-1687; APL-108Phase 1 ClinicalCrescent Biopharma IncAnemia, Sickle Cell; Inflammation; Leukemia, Myeloid, Acute
詳細
PF-07209326PF-07209326Phase 1 ClinicalPfizer IncAnemia, Sickle Cell
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8